Tudor Investment Corp ET AL Makes New Investment in Relx Plc $RELX

Tudor Investment Corp ET AL acquired a new stake in Relx Plc (NYSE:RELX) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 30,168 shares of the technology company’s stock, valued at approximately $1,441,000.

A number of other large investors also recently modified their holdings of RELX. Salomon & Ludwin LLC increased its holdings in shares of Relx by 1,646.2% in the third quarter. Salomon & Ludwin LLC now owns 681 shares of the technology company’s stock valued at $32,000 after purchasing an additional 642 shares in the last quarter. Nisa Investment Advisors LLC lifted its holdings in Relx by 191.7% during the 3rd quarter. Nisa Investment Advisors LLC now owns 700 shares of the technology company’s stock worth $33,000 after buying an additional 460 shares in the last quarter. Elevation Point Wealth Partners LLC bought a new position in Relx in the 2nd quarter valued at $38,000. Bessemer Group Inc. boosted its position in Relx by 104.2% in the 3rd quarter. Bessemer Group Inc. now owns 868 shares of the technology company’s stock valued at $42,000 after buying an additional 443 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in shares of Relx in the 2nd quarter valued at $44,000. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft raised Relx from a “hold” rating to a “buy” rating in a research note on Tuesday, December 9th. Weiss Ratings reissued a “hold (c+)” rating on shares of Relx in a report on Monday, December 29th. Zacks Research downgraded shares of Relx from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 4th. Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research note on Monday, February 2nd. Finally, Wall Street Zen cut shares of Relx from a “buy” rating to a “hold” rating in a research report on Saturday, March 7th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Relx Stock Performance

RELX stock opened at $31.96 on Monday. Relx Plc has a twelve month low of $27.57 and a twelve month high of $56.33. The company has a debt-to-equity ratio of 2.38, a current ratio of 0.49 and a quick ratio of 0.44. The business’s fifty day moving average is $33.79 and its 200-day moving average is $39.86.

Relx (NYSE:RELX) last announced its quarterly earnings data on Wednesday, February 11th. The technology company reported $42.81 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $41.96. The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $6.70 billion. Research analysts predict that Relx Plc will post 1.68 earnings per share for the current fiscal year.

Relx Dividend Announcement

The business also recently announced a dividend, which will be paid on Wednesday, June 24th. Stockholders of record on Friday, May 8th will be given a dividend of $0.6559 per share. This represents a dividend yield of 422.0%. The ex-dividend date is Friday, May 8th.

Relx Company Profile

RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.

RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.